This research study is looking into the effects of clavulanic on smoking behavior in adult cigarette smokers. The primary study hypothesis is that, compared to placebo, clavulanic acid will reduce smoking over the course of the study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Enrollment
30
Beta lactamase inhibitor for smoking cessation
placebo
University of Missouri - Columbia
Columbia, Missouri, United States
RECRUITINGCigarette Smoking
Biochemical smoking assessment (breath carbon monoxide) at each study visit.
Time frame: 5 days
Self Reported Side Effects
Number of reported side effects
Time frame: 5 Days
Magnitude of change in BOLD fMRI brain response to smoking related images
Measure the effects of Clavulanic Acid on fMRI BOLD response to images (change from baseline to end of study) while participants undergo functional magnetic resonance imaging
Time frame: 4 days
Magnitude of change in resting-stated fMRI brain connectivity
Measure the effects of Clavulanic Acid on resting-state functional connectivity (change from baseline to end of study) while participants undergo functional magnetic resonance imaging.
Time frame: 4 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.